All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer ...